Month: October 2018

Notizia

Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant

TherapeuticsMD bags FDA approval for hormone therapy The FDA has nodded hormone therapy of TherapeuticsMD for hot flashes that are...

Read More

Meeting the Unmet Need for Oral Mucositis

Articles, Business Consultant, DelveInsight's Drug Report, Pharma Consultant

Oral Mucositis (OM) refers to erythematous and ulcerative lesions of the oral mucosa observed in cancer patients under chemotherapy or...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

Novartis comes up with an answer for breast cancer with PI3K drug alpelisib Novartis comes up with an answer with its recent data on...

Read More

INSIGHTS ON TRIPLE NEGATIVE BREAST CANCER

Business Consultant, Infographics, Pharma Consultant • 3 Comments

  To know more about TRIPLE NEGATIVE BREAST CANCER request for sample...

Read More

Drugmakers will now have to reveal medicine prices in television ads

Business Consultant, Pharma Consultant, Snippets

Pharmaceutical companies will disclose the price of medicines in television advertisements to consumers. The step is taken up by the Trump...

Read More

Notizia

Business Consultant, Notizia, Pharma Consultant

FDA approves expanded label for Xarelto of Johnson & Johnson The Food and Drug Administration permitted labelling of blood thinner,...

Read More
Close